Copiar e Editar

Non-Small Cell Lung Cancer Treatment Regimens

Descrição

Understand U.S., Western Europe, and Japanese markets for first/second/third line treatment for NSCLC with regards to Stage (I-IV) and histology/biomarkers (squamous, non-squamous, EGFR mutant, and ALK mutant).
Shane Naki
Mapa Mental por Shane Naki, atualizado more than 1 year ago
Shane Naki
Criado por Shane Naki quase 10 anos atrás
14
0
0

Resumo de Recurso

Non-Small Cell Lung Cancer Treatment Regimens
  1. Systemic Regimens by Country
    1. United States (2015)
      1. Carboplatin + Alimta + Avastin
        1. Carboplatin + paclitaxel
          1. Xalkori
            1. Tarceva
              1. United States
                1. docetaxel
                  1. docetaxel
                    1. Gilotrif
                      1. Zykdaia
                        1. United States
                          1. Opdivo
                            1. Tarceva
                              1. Opdivo
                                1. Opdivo
                            2. Western Europe (2015)
                              1. cisplatin + gemcitibine
                                1. Cisplatin + Alimta
                                  1. Tarceva
                                    1. Xalkori
                                      1. Western Europe
                                        1. docetaxel
                                          1. docetaxel
                                            1. cisplatin + Alimta
                                              1. Xalkori
                                                1. Western Europe
                                                  1. Vinorelbine
                                                    1. Vinorelbine
                                                      1. Vinorelbine
                                                        1. vinorelbine
                                                    2. Japan (2014)
                                                          2. Treatment Line
                                                            1. 1
                                                              1. Squamous
                                                                1. Non-Squamous
                                                                  1. EGFR mutant
                                                                    1. ALK Mutant
                                                                2. 2
                                                                  1. 3
                                                                    1. Squamous
                                                                      1. Non-Squamous
                                                                        1. EGFR Mutant
                                                                          1. ALK Mutant
                                                                    2. Squamous
                                                                      1. Non-Squamous
                                                                        1. EGFR Mutant
                                                                          1. ALK Mutant

                                                                Quer criar seus próprios Mapas Mentais gratuitos com a GoConqr? Saiba mais.

                                                                Semelhante

                                                                QuintilesIMS Institute 2016: Outlook for Global Medicine through 2021
                                                                Shane Naki
                                                                Explore a Biblioteca